Answers are grounded in this paper and cite their sources.
Patients with subclinical PHT have less hyperdynamic circulation and significantly lower portal pressure reduction after acute β-blockade than those with CSPH, suggesting that β-blockers are more suitable to prevent decompensation of cirrhosis in patients with CSPH than in earlier stages.
No takes yet. Share an insight, caveat, or question.
Villanueva et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: